RxDoctor Payments Data

James Paxton, MD

Emergency Medicine · Detroit, MINPI 1063622793

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.0%), food and beverage and grants — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Vertex at 57.9% of the total. Among emergency medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,771in general payments, 2019–2025

Across 17 payments — averaging $574.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertex$6K
  • Sanofi$2K
  • AOP Health US, LLC$1K
  • Quidel Corporation$400
  • Abbott$143
  • AstraZeneca$118
  • plus $202 from 2 others
$481,486in research payments, 2019–2025

Across 17 payments — averaging $28,323 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Instrumentation Laboratory Company$389K
  • Pfizer$79K
  • CSL Behring$13K

What the payments were for

  • Consulting fees$4,78549%
  • Grants$2,00020%
  • Travel & lodging$98210%
  • Food & beverage$2,00521%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vertex9$5,661
Sanofi2$2,000
AOP Health US, LLC1$1,248
Quidel Corporation1$400
Abbott1$143
AstraZeneca1$118
Genentech USA, Inc.1$103
Teleflex LLC1$100

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,771 in reported general payments places this provider in the 95th percentile of 2,532 emergency medicine providers in Michigan.

See all emergency medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$24,895
Medicare patients
139
Services billed
205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naproxen17$48

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →